{
    "organizations": [],
    "uuid": "ad9f9d8f3c1504d9666be37d72bc318d6742a52e",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-avenue-therapeutics-reports-q4-los/brief-avenue-therapeutics-reports-q4-loss-per-share-0-63-idUSASB0C8A9",
    "ord_in_thread": 0,
    "title": "Avenue Therapeutics Reports Q4 Loss Per Share $0.63",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 1 (Reuters) - Avenue Therapeutics Inc:\n* AVENUE THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND RECENT CORPORATE HIGHLIGHTS\n* Q4 LOSS PER SHARE $0.63 Source text for Eikon: (Reuters.Brief@thomsonreuters.com)\n ",
    "published": "2018-03-01T20:33:00.000+02:00",
    "crawled": "2018-03-02T19:47:09.026+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "avenue",
        "therapeutic",
        "inc",
        "avenue",
        "therapeutic",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "recent",
        "corporate",
        "highlight",
        "q4",
        "loss",
        "per",
        "share",
        "source",
        "text",
        "eikon"
    ]
}